» Articles » PMID: 11278337

Retention of the Alzheimer's Amyloid Precursor Fragment C99 in the Endoplasmic Reticulum Prevents Formation of Amyloid Beta-peptide

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Mar 30
PMID 11278337
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

gamma-Secretase is a membrane-associated endoprotease that catalyzes the final step in the processing of Alzheimer's beta-amyloid precursor protein (APP), resulting in the release of amyloid beta-peptide (Abeta). The molecular identity of gamma-secretase remains in question, although recent studies have implicated the presenilins, which are membrane-spanning proteins localized predominantly in the endoplasmic reticulum (ER). Based on these observations, we have tested the hypothesis that gamma-secretase cleavage of the membrane-anchored C-terminal stump of APP (i.e. C99) occurs in the ER compartment. When recombinant C99 was expressed in 293 cells, it was localized mainly in the Golgi apparatus and gave rise to abundant amounts of Abeta. Co-expression of C99 with mutant forms of presenilin-1 (PS1) found in familial Alzheimer's disease resulted in a characteristic elevation of the Abeta(42)/Abeta(40) ratio, indicating that the N-terminal exodomain of APP is not required for mutant PS1 to influence the site of gamma-secretase cleavage. Biogenesis of both Abeta(40) and Abeta(42) was almost completely eliminated when C99 was prevented from leaving the ER by addition of a di-lysine retention motif (KKQN) or by co-expression with a dominant-negative mutant of the Rab1B GTPase. These findings indicate that the ER is not a major intracellular site for gamma-secretase cleavage of C99. Thus, by inference, PS1 localized in this compartment does not appear to be active as gamma-secretase. The results suggest that presenilins may acquire the characteristics of gamma-secretase after leaving the ER, possibly by assembling with other proteins in peripheral membranes.

Citing Articles

Presenilin 1 Modulates Acetylcholinesterase Trafficking and Maturation.

Cortes-Gomez M, Barbera V, Alom J, Saez-Valero J, Garcia-Ayllon M Int J Mol Sci. 2023; 24(2).

PMID: 36674948 PMC: 9864477. DOI: 10.3390/ijms24021437.


The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma.

Li Z, Mbah N, Overmeyer J, Sarver J, George S, Trabbic C BMC Cancer. 2019; 19(1):77.

PMID: 30651087 PMC: 6335761. DOI: 10.1186/s12885-019-5288-y.


6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.

Du S, Sarver J, Trabbic C, Erhardt P, Schroering A, Maltese W Cancer Chemother Pharmacol. 2018; 83(2):237-254.

PMID: 30426158 PMC: 6645365. DOI: 10.1007/s00280-018-3726-1.


Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease.

Wang X, Zhou X, Li G, Zhang Y, Wu Y, Song W Front Mol Neurosci. 2017; 10:294.

PMID: 28966576 PMC: 5605621. DOI: 10.3389/fnmol.2017.00294.


Vacuole-inducing compounds that disrupt endolysosomal trafficking stimulate production of exosomes by glioblastoma cells.

Li Z, Mbah N, Maltese W Mol Cell Biochem. 2017; 439(1-2):1-9.

PMID: 28770472 PMC: 5796851. DOI: 10.1007/s11010-017-3130-x.